Roche CEO Thomas Schinecker to Lead IFPMA as New President

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has appointed Dr. Thomas Schinecker, CEO of Roche, as its new President, effective January 1, 2025. Schinecker, who served as IFPMA Vice-President for two years, will be joined by Rob Davis, CEO of MSD, as the Vice-President. The leadership transition follows the completion of Dr. Albert Bourla’s term as President.

Leadership Transition in IFPMA

Schinecker’s appointment marks a significant shift in IFPMA’s leadership. As outgoing President, Dr. Albert Bourla emphasized the organization’s role in driving innovative medicines and vaccines. Schinecker, in his new role, aims to propel the industry forward with bold policies and pioneering innovations.

2023 Highlights: Roche’s Resilient Performance

In his first letter to shareholders, Schinecker shared Roche’s 2023 performance, detailing significant growth despite the decline in COVID-19-related sales. Roche achieved a sales figure of CHF 58.7 billion, driven by strong demand for innovative treatments like Vabysmo, Columvi, and Lunsumio. These therapies provided hope for patients with conditions like age-related macular degeneration and blood cancer.

Focus on Innovation and Strategic Partnerships

Schinecker reaffirmed Roche’s commitment to innovation, highlighted by partnerships with Alnylam and Telavant to treat high blood pressure and inflammatory bowel disease. Roche also achieved breakthroughs in diagnostics, with new immunoassays setting standards for conditions like sepsis in newborns. Schinecker emphasized that digitalisation and artificial intelligence will play a key role in future innovation, further strengthening Roche’s R&D pipeline.

A Vision for the Future

Looking ahead, Schinecker’s focus will be on expanding Roche’s research and development capabilities and enhancing digital solutions in drug development. With a rich history of breakthroughs across various medical fields, Roche is uniquely positioned to continue its leadership in pharmaceuticals and diagnostics globally.

Summery of the news

Why in News Details
Dr. Thomas Schinecker appointed President of IFPMA CEO of Roche, Dr. Schinecker, to take over as IFPMA President on January 1, 2025, after Dr. Albert Bourla completes his term.
Key Leadership Transition Dr. Schinecker was IFPMA Vice-President for 2 years. Rob Davis, CEO of MSD, appointed as Vice-President.
IFPMA’s Role in Pharma IFPMA is a global trade body representing pharmaceutical manufacturers, emphasizing innovation and policy leadership.
2023 Roche Performance Roche reported a sales increase of 1% in 2023, totaling CHF 58.7 billion. Vabysmo, Columvi, and Lunsumio were key product highlights.
Breakthrough Medicines Vabysmo for eye diseases, Columvi and Lunsumio for blood cancer. Alecensa and Inavolisib for lung and breast cancers.
Roche’s Strategic Acquisitions Partnerships with Alnylam for high blood pressure treatment, and Telavant for inflammatory bowel disease.
Roche’s Focus Areas in 2023 Emphasis on digital solutions, AI in drug development, and breakthroughs in diagnostics (e.g., Elecsys IL-6 for sepsis).
Roche’s CEO Focus Strengthening R&D pipeline, enhancing innovation, and advancing digital solutions in pharmaceutical development.
Roche Global Operations Roche has over 100,000 employees and is a leader in oncology, neuroscience, ophthalmology, and in-vitro diagnostics.
Piyush Shukla

Recent Posts

India and Japan Conduct JAIMEX 2026: Key Activities and Significance

The India-Japan bilateral naval exercise JAIMEX 2026 took place on the 13 th and 14…

34 minutes ago

Manu Bhaker Elected to ISSF Athletes Committee for 2026–2030 Term

Indian Shooter Manu Bhaker, who has won two Olympic medals, has been elected onto the…

51 minutes ago

India re-elected to International Telecommunication Union Council for 2027-2030 term

India has been successfully re-elected to the Council of the International Telecommunication Union (ITU) for…

2 hours ago

MS Dhoni Retires from IPL, Named CSK mentor for 2027 Season

Former India & Chennai Super Kings captain Mahendra Singh Dhoni has retired from the Indian…

2 hours ago

What is Mekedatu Dam Project? Why Karnataka Wants It and Why Tamil Nadu Opposes It

The Mekedatu Dam Project is a proposal for building a balancing reservoir and drinking water…

3 hours ago

AIIMS Delhi Performs India’s First Open Fetal Surgery to Repair Spinal Defect

Doctors at the All India Institute of Medical Sciences (AIIMS) in New Delhi have completed…

4 hours ago